Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,600 | 2 | 93.2% |
| Food and Beverage | $294.34 | 3 | 6.0% |
| Education | $42.76 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $4,600 | 2 | $0 (2024) |
| CSL Behring | $112.42 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $104.46 | 1 | $0 (2017) |
| Novo Nordisk Inc | $77.46 | 1 | $0 (2022) |
| Agios Pharmaceuticals, Inc. | $42.76 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,875 | 1 | PFIZER INC. ($2,875) |
| 2023 | $1,725 | 1 | PFIZER INC. ($1,725) |
| 2022 | $232.64 | 4 | CSL Behring ($112.42) |
| 2017 | $104.46 | 1 | Alexion Pharmaceuticals, Inc. ($104.46) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,875.00 | General |
| 05/22/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,725.00 | General |
| 11/07/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Education | In-kind items and services | $21.38 | General |
| Category: Genetically Defined Disease | ||||||
| 08/16/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $112.42 | General |
| 08/16/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $77.46 | General |
| 08/09/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Education | In-kind items and services | $21.38 | General |
| Category: Genetically Defined Disease | ||||||
| 09/07/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $104.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 98 | 131 | $42,045 | $8,446 |
| 2022 | 4 | 95 | 126 | $40,590 | $8,210 |
| 2021 | 3 | 89 | 118 | $39,530 | $8,092 |
| 2020 | 4 | 80 | 98 | $30,910 | $5,444 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 74 | $18,870 | $3,736 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 42 | $15,750 | $3,053 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $7,425 | $1,657 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 52 | $19,500 | $3,693 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 47 | $11,985 | $2,303 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 15 | $7,425 | $1,829 | 24.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 12 | $1,680 | $385.11 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 44 | $16,500 | $3,609 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 61 | $15,555 | $3,094 | 19.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $7,475 | $1,389 | 18.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 51 | $13,005 | $1,964 | 15.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $9,775 | $1,874 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 15 | $5,625 | $946.00 | 16.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 15 | $2,505 | $660.36 | 26.4% |
About Dr. Robert Bona, MD
Dr. Robert Bona, MD is a Hematology & Oncology healthcare provider based in Farmington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124024559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Bona, MD has received a total of $4,937 in payments from pharmaceutical and medical device companies, with $2,875 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($4,600).
As a Medicare-enrolled provider, Bona has provided services to 362 Medicare beneficiaries, totaling 473 services with total Medicare billing of $30,192. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Farmington, CT
- Active Since 06/21/2005
- Last Updated 01/15/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1124024559
Products in Payments
- SOLIRIS (Drug) $104.46
- PYRUKYND (Drug) $42.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Farmington
Biree Andemariam, Md, MD
Hematology & Oncology — Payments: $588,126
Aakash Desai, Mbbs, MBBS
Hematology & Oncology — Payments: $42,232
Dr. Sardar Imam, M.d, M.D
Hematology & Oncology — Payments: $37,197
Ankit Anand, M.d, M.D
Hematology & Oncology — Payments: $16,232
Dr. Jeffrey Neidhart, Md, MD
Hematology & Oncology — Payments: $13,104
Susan Tannenbaum, Md, MD
Hematology & Oncology — Payments: $6,994